Navigation Links
Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimer's Disease
Date:10/15/2007

ing. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including the outcome of clinical trials of Memory Pharmaceuticals' drug candidates and whether they demonstrate these candidates' safety and effectiveness; the risks and uncertainties associated with: obtaining additional financing to support Memory Pharmaceuticals' R&D and clinical activities and operations; obtaining regulatory approvals to conduct clinical trials and to commercialize Memory Pharmaceuticals' drug candidates; Memory Pharmaceuticals' ability to enter into and maintain collaborations with third parties for its drug development programs; Memory Pharmaceuticals' dependence on its collaborations and its license relationships; achieving milestones under Memory Pharmaceuticals' collaborations; Memory Pharmaceuticals' dependence on preclinical and clinical investigators, preclinical and clinical research organizations, manufacturers and consultants; and protecting the intellectual property developed by or licensed to Memory Pharmaceuticals. These and other risks are described in greater detail in Memory Pharmaceuticals' filings with the Securities and Exchange Commission. Memory Pharmaceuticals may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. Memory Pharmaceuticals disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.


'/>"/>
SOURCE Memory Pharmaceuticals Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
4. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
5. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
10. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
11. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... Massachusetts and LONDON , August ... approach seamlessly connects ... continuum improving outcomes and the ...  (NYSE: PHG AEX: PHIA) today announced its presence at  ... latest cardiology solutions, including Heart Model A.I. , EchoNavigator and ...
(Date:8/27/2015)...  A recent study by Feucht et al, ... Arthrosurface HemiCAP® Wave implant, which is based on ... implant for isolated patellofemoral disease. While both implant ... scores, none of the patients in the "inlay" ... of the patients in the "onlay" group, showed ...
(Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
Breaking Medicine Technology:Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 2Study Demonstrates Dramatic Reduction in Progression of Osteoarthritis with the Arthrosurface "Inlay" Patellofemoral Implant Design Compared to Traditional "Onlay" Implant 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4
... 2011 Prescription monitoring laboratory and clinical partner ... its Safe Use Treatment Monitoring Solution™. Consistent with ... compliant with the FDA,s Opioid Risk and Evaluation ... for controlled substances.  The program aims to support ...
... As NFL coaches and players face a dramatically shortened ... preparation will be gaining a competitive edge as it defends ... Polar USA and the Atlanta Falcons announced that the Polar ... Rate Training System" of the Atlanta Falcons. In ...
Cached Medicine Technology:Dominion Diagnostics Leads Fight Against Prescription Drug Abuse with Safe Use Treatment Monitoring Solution 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 2Polar Team2 Pro Set Solution Is Official Heart Rate Training System for the Atlanta Falcons 3
(Date:8/28/2015)... Omaha, Neb. (PRWEB) , ... August 28, 2015 , ... ... among the 2015 Best Places to Work in Healthcare by Modern Healthcare ... , Now in its eighth year, the Best Places to Work ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... accreditation for its adolescent residential, counseling, day treatment and intensive family based services. ... international standards for quality and its pursuit of excellence. As a nonprofit charity ...
(Date:8/28/2015)... ... 2015 , ... SmartPractice Calendars afford dental offices ... contact information and logos, Calendars stand alone as functional brand-building giveaways ... mailings, thank you and welcome communications, and to complement statements and invoices. 2016 ...
(Date:8/28/2015)... CA (PRWEB) , ... August 28, 2015 , ... ... price on Zoom teeth whitening. For just $199, patients can currently receive a one ... traditional in-office teeth whitening procedures, but it includes a number of unique features that ...
(Date:8/28/2015)... ... August 28, 2015 , ... SharkNinja, an innovative ... connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil the Ninja® brand’s new ... technology, which delivers a variety of sizes and styles while achieving the perfect ...
Breaking Medicine News(10 mins):Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3
... SAN FRANCISCO Young, athletic, first-time shoulder dislocation patients ... study released today at the 2008 American Orthopaedic Society ... The study found that for highly active patients, ... In young, active patients, there were statistics as high ...
... Our Colleague, COSTA MESA, Calif., March 7 ... Cross of California in,support of 46-year-old Kim Kutcher, RN, ... her to a possible lifetime of disability by denying,her ... important., The nurses will accompany the family and ...
... Two major defendants - AstraZeneca and Bristol-Myers Squib - not part ... ... BOSTON, March 7 Today eleven major pharmaceutical,companies, including Abbott Laboratories ... to a $125 million nationwide settlement,in the average wholesale price (AWP) ...
... NORTH ADAMS, Mass., March 7 Recognizing the ... safety and health care,quality, today the National Patient ... Patient Compact to complement the Consumer Bill,of Rights ... on,principles contained in the Consumer Bill of Rights ...
... BWF has named 13 translational researchers as the ... Translational Research. The awards, which provide $150,000 ... to support established, independent physician-scientists who are dedicated ... and patient treatmentand mentoring physician-scientist trainees. , ...
... Drug,Stores Corporation (NYSE: LDG ) today announced ... president and chief operating officer, effective,immediately. He succeeds ... will,be responsible for store operations, marketing, merchandising, construction,and ... as senior vice president of marketing. He,was named ...
Cached Medicine News:Health News:Controversial shoulder surgery for first-time dislocation proven effective long-term 2Health News:RNs, Family Protest Denial of Critical Surgery for Orange County ICU Nurse 2Health News:RNs, Family Protest Denial of Critical Surgery for Orange County ICU Nurse 3Health News:Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation 2Health News:Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation 3Health News:National Patient Safety Foundation Proposes Universal Patient Compact 2Health News:National Patient Safety Foundation Proposes Universal Patient Compact 3Health News:Burroughs Wellcome Fund grants $9.75 million towards translational researchers 2Health News:Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 2
Soft PVC. Available in sizes 12-36F, Interior striations for smooth suction catheter insertion. Bevel tip. Single use. Sterile....
Soft Guedel Oral Airways...
... airways., ,When a difficult airway must ... Now you can be assured of rapid ... Esophageal/Tracheal double-Lumen Airway from Nellcor. Unlike traditional ... to establish a nonsurgical patient airway when ...
All oral and nasal airways are manufactured with smooth, rounded edges for increased patient comfort and safety., ,Portex® offers a broad selection of airways for a variety of clinical applicati...
Medicine Products: